Streetbeat News

Price Targets

MMM

Five analysts have recently updated their ratings on 3M (NYSE:MMM), with four maintaining an indifferent stance and one rating it as somewhat bearish. The average 12-month price target is now $103.2, up from $102.60, with individual analysts adjusting their targets both upwards and downwards. 3M's financials show a revenue decline of -3.56%, a high net margin of -24.96%, an ROE of -33.28%, an ROA of -4.21%, and a debt-to-equity ratio of 3.6, indicating mixed financial health and potential risks.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:00 pm

MGNX

Macrogenics (NASDAQ:MGNX) received mixed reviews from 5 analysts, with recent ratings ranging from bullish to somewhat bullish. The average 12-month price target is $14.00, a significant increase from the previous $10.33. Analysts from JMP Securities, Citigroup, Stifel, HC Wainwright & Co., and Guggenheim have adjusted their price targets and ratings, reflecting changes in market dynamics and company performance. Macrogenics, a biotech company specializing in antibody-based cancer therapeutics, has a market cap below industry benchmarks and experienced a significant revenue decline of -75.09% over the last quarter. However, it has a high net margin of 168.84%, an ROE of 9.6%, and an ROA of 5.44%, indicating strong profitability and financial management.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:00 pm

YOU

Needham analyst Joshua Reilly has reiterated a Buy rating on Clear Secure (NYSE:YOU) and maintained a $40 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:31 pm

GATX

Susquehanna analyst Bascome Majors has maintained a Neutral rating on GATX (NYSE:GATX) and increased the price target from $115 to $120.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:27 pm

RTO

Rentokil Initial's stock is trading lower following a downgrade by B of A Securities from Buy to Neutral, with a reduced price target from $40 to $29.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:23 pm

WIX

JMP Securities analyst Andrew Boone has maintained a Market Outperform rating on Wix.com (NASDAQ:WIX) and increased the price target from $130 to $150.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:21 pm

MGNX

JMP Securities analyst Silvan Tuerkcan has reaffirmed a Market Outperform rating on Macrogenics (NASDAQ:MGNX) and increased the price target from $10 to $16, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:18 pm

DHI

JMP Securities analyst Aaron Hecht has maintained a Market Outperform rating on D.R. Horton (NYSE:DHI) and increased the price target from $140 to $170.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:16 pm

BNTC

JMP Securities analyst Silvan Tuerkcan has maintained a Market Outperform rating on Benitec Biopharma (NASDAQ:BNTC) and increased the price target from $6 to $8.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:14 pm

XP

XP Inc. shares are experiencing an uptick following an upgrade from Neutral to Outperform by Banco Bradesco BBI S.A, which also set a price target of $32 for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:11 pm